Transplantation of NAT+HCV Donor Lungs into Non-Infected Recipients Followed by Treatment with Sofosbuvir/Velpatasvir (S/V)

One of the most promising strategies to increase organ donation is the use of organs from donors with Hepatitis C (HCV). We evaluated the safety of transplanting NAT+HCV donors into non-infected lung recipients.

Source: The Journal of Heart and Lung Transplantation - March 16, 2019 Category: Transplant Surgery Authors: M. Cypel, J. Feld, L.G. Singer, N. Marks, I. Bahinskaya, M. Kuczynski, D. Kumar, M. Galasso, R. Ribeiro, J. Yeung, L. Donahoe, A. Pierre, M. de Perrot, K. Yasufuku, T.K. Waddell, S. Keshavjee, A. Humar, A. Humar Tags: 136 Source Type: research